Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Journal of Obesity & Metabolic Syndrome|May 13, 2024
Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and MechanismsShaghayegh Khanmohammadi, Mohammad Shafi KuchayIndian Journal of Endocrinology and Metabolism|May 2, 2017
Levosulpiride and Serum Prolactin LevelsMohammad Shafi Kuchay, Ambrish MithalDiabetes & Metabolic Syndrome|March 8, 2022
Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosisMohammad Shafi Kuchay, Anoop MisraPharmacological Research|October 17, 2022
Toll-like receptors and metabolic (dysfunction)-associated fatty liver diseaseShaghayegh Khanmohammadi, Mohammad Shafi KuchayIndian Journal of Endocrinology and Metabolism|October 2, 2015
Hemoglobin E disease and glycosylated hemoglobinNiharika Yedla, Mohammad Shafi Kuchay, Ambrish MithalDiabetes & Metabolic Syndrome|May 7, 2024
Intrahepatic hypothyroidism in MASLD: Role of liver-specific thyromimetics including resmetiromMohammad Shafi Kuchay, Scott Isaacs, Anoop MisraClinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 23, 2018
Pitfalls in interpreting interventional studies for osteoporosisMohammad Shafi Kuchay, Beena Bansal, Ambrish MithalClinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|July 26, 2017
Acute severe diarrhoea and hyponatremia after zoledronic acid infusion: an acute phase reactionMohammad Shafi Kuchay, Khalid Jamal Farooqui, Ambrish MithalDiabetes & Metabolic Syndrome|January 5, 2021
New onset diabetes, type 1 diabetes and COVID-19Sirisha Kusuma Boddu, Geeta Aurangabadkar, Mohammad Shafi KuchayDiabetes & Metabolic Syndrome|June 11, 2023
NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptorsShaghayegh Khanmohammadi, Bruno Ramos-Molina, Mohammad Shafi KuchayPageof 8